ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2222

Spinal Mobility Measures in Normal Individuals – the Mobility Study

Sofia Ramiro1, Carmen Stolwijk2, A.M. Van Tubergen3, Désirée van der Heijde4 and Robert Landewé5, 1Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, The Netherlands and Hospital Garcia de Orta, Almada, Portugal, 2Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Department of Medicine, Maastricht University Medical Center, Maastricht, Netherlands, 4Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Outcome measures and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: Spinal mobility is one of the core outcomes recommended by the Assessment of Spondyloarthritis international Society (ASAS) for following patients with axial SpA. It is currently unknown how these spinal mobility measures perform in healthy subjects and to what extent they are influenced by age, gender and height. We aimed to assess the effect of age, gender and height on spinal mobility measures among healthy individuals.

Methods: A cross-sectional study (“MOBILITY-study”) was conducted in healthy volunteers aged 20-69 years old. Recruitment was stratified by gender, age (10-year categories) and height (10cm categories). Participants were Caucasians volunteering to be measured in the Netherlands and Portugal. Exclusion criteria were factors potentially influencing spinal mobility (such as previous back surgery, known spinal osteoarthritis or low back pain). The following measures were assessed: tragus-to-wall distance (TTW, cm), occiput-to-wall distance (OTW, cm), lateral spinal flexion (LSF, cm), cervical rotation (CR, degrees), intermalleolar distance (IMD, cm), chest expansion (CE, cm) and Schober’s test. The Bath Ankylosing Spondylitis Mobility Index (BASMI) was computed. The effects of age, gender, height and weight were investigated using linear regression analyses (univariable followed by multivariable, forward selection procedure), adjusting for potential confounders and taking relevant interactions into account.

Results: 393 volunteers were included. A significant decrease in all spinal mobility measures was found by increasing age, and age was included in all multivariable models (some of the models are presented in the table). E.g. an increase of 10 years was associated with a decrease of 1.5cm in LSF or a decrease of 3.4cm in IMD. Height was associated with the following spinal mobility measures: TTW, LSF, CE, IMD and BASMI, with a higher height being associated with better mobility. E.g. every increase in height of 10cm resulted in an increase of 4.2cm in IMD, an increase of 0.3cm in LSF and an increase of 1.1cm in CE.  Gender was associated with CE and CR, with women having a worse mobility. Weight was positively associated with TTW, OTW and Schober’s test: An increase of 10kg resulted in an increase of 0.3cm in TTW, 0.2cm in OTW and 0.2cm in Schober’s test. There was a significant interaction between the effects of age and gender on BASMI: in women, age was the only factor with a significant effect on BASMI (β 0.03, 95%CI 0.03; 0.04). In men, age (β 0.03, 95%CI 0.02; 0.04), and weight (β -0.01, 95%CI -0.01; -0.00) significantly contributed to BASMI.

Conclusion: All spinal mobility measures decrease with increasing age. Height significantly influences some spinal mobility measures, especially IMD and LSF. These factors have to be taken into account when assessing patients’ spinal mobility, and should be included in reference values for these measurements.

 

Table – Effect of age, gender, height and weight on spinal mobility measures

Measure

Univariable linear regression β (95% CI)

Multivariable linear regression β (95% CI)

Lateral spinal flexion (cm)

Age (years)

-0.15 (-0.17; -0.13)

-0.15 (-0.17; -0.13)

Gender (female vs male)

-0.50 (-1.23; 0.23)

 

Height (cm)

0.03 (0.00; 0.06)

0.03 (0.00; 0.07)

Weight (kg)

-0.01 (-0.04; 0.01)

-0.01 (-0.04; 0.02)

Intermalleolar distance (cm)

Age (years)

-0.46 (-0.42; -0.27)

-0.44 (-0.53; -0.36)

Gender (female vs male)

-1.05 (-3.92; 1.83)

 

Height (cm)

0.44 (0.33; 0.55)

0.42 (0.33; 0.52)

Weight (kg)

0.14 (0.05; 0.23)

 

Cervical rotation (degrees)

Age (years)

-0.35 (-0.42; -0.27)

-0.34 (-0.42; -0.27)

Gender (female vs male)

-4.13 (-6.43; -1.82)

-3.83 (-5.89; -1.77)

Height (cm)

0.12 (0.03; 0.21)

 

Weight (kg)

-0.03 (-0.10; 0.04)

 

BASMI (0-10)

Age (years)

0.03 (0.03; 0.04)

Significant interaction age X gender (see text)

Gender (female vs male)

0.21 (0.05; 0.38)

Height (cm)

-0.01 (-0.02; -0.00)

Weight (kg)

-0.00 (-0.01; 0.00)


Disclosure:

S. Ramiro,
None;

C. Stolwijk,
None;

A. M. Van Tubergen,
None;

D. van der Heijde,
None;

R. Landewé,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spinal-mobility-measures-in-normal-individuals-the-mobility-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology